Pharmagreen Biotech (Pharmagreen Biotech) EV-to-EBIT : -1.96 (As of May. 20, 2024)

View and export this data going back to 2008. Start your Free Trial

What is Pharmagreen Biotech EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Pharmagreen Biotech's Enterprise Value is $0.79 Mil. Pharmagreen Biotech's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was $-0.41 Mil. Therefore, Pharmagreen Biotech's EV-to-EBIT for today is -1.96.

The historical rank and industry rank for Pharmagreen Biotech's EV-to-EBIT or its related term are showing as below:

PHBI' s EV-to-EBIT Range Over the Past 10 Years
Min: -412.09 Med: 0 Max: 471
Current: -1.96

During the past 7 years, the highest EV-to-EBIT of Pharmagreen Biotech was 471.00. The lowest was -412.09. And the median was 0.00.

PHBI's EV-to-EBIT is ranked worse than
100% of 667 companies
in the Drug Manufacturers industry
Industry Median: 17.86 vs PHBI: -1.96

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Pharmagreen Biotech's Enterprise Value for the quarter that ended in Jun. 2023 was $1.16 Mil. Pharmagreen Biotech's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was $-0.41 Mil. Pharmagreen Biotech's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2023 was -34.92%.

Pharmagreen Biotech EV-to-EBIT Historical Data

The historical data trend for Pharmagreen Biotech's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmagreen Biotech EV-to-EBIT Chart

Pharmagreen Biotech Annual Data

Trend

Apr08

Apr09

Sep18

Sep19

Sep20

Sep21

Sep22

EV-to-EBIT

Get a 7-Day Free Trial

-58.85

-198.05

-4.60

-2.84

-5.68

Pharmagreen Biotech Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
EV-to-EBIT	Get a 7-Day Free Trial															-2.48	-5.68	-1.97	360.41	-2.86

Competitive Comparison of Pharmagreen Biotech's EV-to-EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Pharmagreen Biotech's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pharmagreen Biotech's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Pharmagreen Biotech's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Pharmagreen Biotech's EV-to-EBIT falls into.

Pharmagreen Biotech EV-to-EBIT Calculation

Pharmagreen Biotech's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	0.792	/	-0.405
	=	-1.96

Pharmagreen Biotech's current Enterprise Value is $0.79 Mil.
Pharmagreen Biotech's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.41 Mil.

Pharmagreen Biotech (OTCPK:PHBI) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Pharmagreen Biotech's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Jun. 2023 )	=	EBIT	/	Enterprise Value (Q: Jun. 2023 )
	=	-0.405	/	1.15993175
	=	-34.92 %

Pharmagreen Biotech's Enterprise Value for the quarter that ended in Jun. 2023 was $1.16 Mil.
Pharmagreen Biotech's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.41 Mil.

Pharmagreen Biotech EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Pharmagreen Biotech's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharmagreen Biotech (Pharmagreen Biotech) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pharmagreen Biotech Inc (OTCPK:PHBI) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

112 North Curry Street, Carson, NV, USA, 89703

Website

https://www.pharmagreen.ca

Pharmagreen Biotech Inc is a biotech science company with specialized products and services in the cannabis industry. The company plans to produce and sell tissue culture plantlets and cannabis oil. Its line of nutraceutical products is a proprietary blend of therapeutic plants and mushrooms. It is developing its business model beyond just cannabis, and is focused on near term revenues from its proprietary blend of therapeutic plants and fungi, a nutraceutical wellness product. Utilizing the Company's expertise in plant genetics, Its transgenic program uses the newest technology available to research and create nutraceuticals, protein-based vaccines, and daily supplements with the potential to improve lives and address a wide variety of disease conditions.